UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
------------------
For the month of December 2004
Commission File Number: 001-31368
SANOFI-AVENTIS
(Translation of registrant's name into English)
174, avenue de France, 75013 Paris, FRANCE
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.
Form 20-F [X] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1):_____
Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7):_____
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the information to
the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934.
Yes [ ] No [X]
If "Yes" marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2(b): 82-________
This Report on Form 6-K shall be deemed to be incorporated by reference into
Sanofi-Aventis' (formerly known as Sanofi-Synthelabo) Registration Statement on
Form F-4 (Registration No. 333-112314), as post-effectively amended and declared
effective on November 10, 2004 by the United States Securities Exchange
Commission, and the related prospectus, dated November 10, 2004, filed pursuant
to Rule 424(b) under the United States Securities Act of 1933, as amended, and
shall be part thereof from the date on which this Report is filed, to the extent
not superseded by documents or reports subsequently filed or furnished.
On December 9, 2004, Sanofi-Aventis (formerly known as
Sanofi-Synthelabo) issued the press release attached hereto as Exhibit 99.1
which is incorporated herein by reference.
EXHIBIT LIST
Exhibit No. Description
---------- -----------
Exhibit 99.1 Press Release, dated December 9, 2004, announcing update
of litigation schedules in United States for Plavix(R) and
Lovenox(R).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Dated: December 9, 2004 SANOFI-AVENTIS
By: /s/ Jean-Claude Leroy
---------------------------------
Name: Jean-Claude Leroy
Title: Senior Vice President &
Chief Financial Officer
EXHIBIT INDEX
Exhibit No. Description
---------- -----------
Exhibit 99.1 Press Release, dated December 9, 2004, announcing update
of litigation schedules in United States for Plavix(R) and
Lovenox(R).